Streed, Carl G. Jr.
Michals, Amy
Quinn, Emily
Davis, John A.
Blume, Kylie
Dalke, Katharine B.
Fetterman, David
Garcia, Gabriel
Goldsmith, Elizabeth
Greene, Richard E.
Halem, Jessica
Hedian, Helene F.
Moring, Isabel
Navarra, May
Potter, Jennifer
Siegel, Jennifer
White, William
Lunn, Mitchell R.
Obedin-Maliver, Juno
Funding for this research was provided by:
University Chobanian and Avedisian School of Medicine Department of Medicine Career Investment Award
Article History
Received: 12 January 2024
Accepted: 25 April 2024
First Online: 1 May 2024
Declarations
:
: This study was deemed exempt under 45 CFR 164.514 by the Boston University Medical Campus IRB as H-39148 “Identification and Efficacy of Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) Content in Medical School Curricula” on October 17, 2019. Electronic informed consent was obtained from participants.
: Not applicable.
: Dr. Streed received consultation fees from EverlyWell, L’Oreal, the Research Institute for Gender Therapeutics, and the Texas Health Institute on topics unrelated to this work. Dr. Obedin-Maliver received consultation fees from Ibis Reproductive Health, Hims Inc., Folx Health Inc., and Sage Therapeutics on topics unrelated to this work. Dr. Lunn received consultation fees from Hims Inc., Folx Health Inc., Otsuka Pharmaceutical Development and Commercialization, Inc., and the American Dental Association on topics unrelated to this work.